News
Portfolio Company News
- SecondWave Systems Demonstrates Reduction in Disease Activity in Clinical Study Evaluating Novel Ultrasound-Based Anti-Inflammatory Therapy in Rheumatoid Arthritis
by businesswire on July 15, 2026 at 8:45 pm - SecondWave Systems Announces Professor Paul Peter Tak as New Advisory Board Member and Secures $3M Additional Financing to Accelerate Development of Novel Ultrasound-Based Anti-Inflammatory Therapyby businesswire.com on July 15, 2026 at 8:45 pm
- SecondWave Systems secures over $7 Million from Department of Defense to Accelerate Development and Clinical Study of Novel Anti-Inflammatory Therapy based on Low-Intensity Focused Ultrasound Technologyby businesswire.com on July 15, 2026 at 8:45 pm
- Using Ultrasound Stimulation to Reduce Inflammation in COVID-19 In-Patients
by ucsdhealth on July 14, 2026 at 5:40 pmResearchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
- WVU Cancer Institute brings scalp-cooling service to regional sitesby WVU Medicine on July 7, 2026 at 12:00 pm
MORGANTOWN, W.Va. – Patients receiving treatment at the WVU Cancer Institute’s regional sites will now have access to a new service that may help reduce hair loss. Stephanie Knight, a registered nurse at Princeton Community Hospital, who was diagnosed…
- Cooler Heads Amma System Recognized by Aetna as Medically Necessary for Hair Preservation During Chemotherapy
by by Cooler Heads Care, Inc. on June 24, 2026 at 5:15 pmCooler Heads, maker of the innovative Amma scalp cooling system, today announced that Aetna, one of the nation’s largest health insurers, has recognized scalp cooling, including the Cooler Heads Amma System, as medically necessary for the prevention of chemotherapy-induced hair loss.
- A cold capping system helps a cancer patient keep her hairby capefearvalley.com on June 19, 2026 at 6:29 pm
- Koya Medical to Attend June 2026 Investor Conferences
by koyamedical.com on June 1, 2026 at 12:00 pmKoya Medical has announced its participation in two investor conferences from June 2 to June 4, 2026
- Koya Medical to Present at May 2026 Investor Conferencesby koyamedical.com on May 1, 2026 at 12:00 pm
Koya CEO Andy Doraiswamy and CFO Damian Rippole participate in RBC Capital Markets Global Healthcare Conference and Wells Fargo Virtual Private MedTech Symposium.
- Mindera Health™ Awarded New York State Department of Health Approval for Mind.Px™
by Mindera on April 22, 2026 at 8:27 pmDecision brings precision medicine in psoriasis to all 50 states Vista, CA, April 22, 2026 (GLOBE NEWSWIRE) — Mindera Health, a leader in precision medicine for dermatological conditions, today announced it has received approval from the New York State Department of Health for its Mind.Px test. Mind.Px is a genomic test that utilizes the proprietary
- About
by Cerene Cryotherapy on April 16, 2026 at 1:42 am - Patient Experience Underscores Market Potential for FDA-Cleared Scalp Cooling Device
by TipRanks Private Companies Auto-Generated Newsdesk on April 10, 2026 at 12:05 amAccording to a recent LinkedIn post from Cooler Heads, the company is highlighting a patient experience using its Amma scalp cooling device during chemotherapy. The…
- FDA Grants PMA Approval to LimiFlex® Dynamic Sagittal Tether
by Guest User on April 3, 2026 at 10:19 pmThe U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex Dynamic Sagittal Tether , a motion-preserving system for the treatment of lumbar spinal stenosis associated with Grade I degenerative spondylolisthesis following decompression.
- Mindera Health™ and Mountaineer Biosciences Launch Subtilitas, a Precision Translational Medicine Platform for Dermatology and Immunologyby Mindera on March 18, 2026 at 8:25 pm
Vista, CA, March 18, 2026 (GLOBE NEWSWIRE) — Mindera Health, a leader in precision medicine for dermatological conditions, and Mountaineer Biosciences today announced the launch of Subtilitas, a precision translational medicine platform designed to bring objective, molecular-level insights into dermatology and immunology clinical research Subtilitas integrates non-invasive skin sampling, advanced molecular profiling, and artificial intelligence/machine
- Koya Medical to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conferenceby koyamedical.com on March 12, 2026 at 12:00 pm
CEO Andy Doraiswamy highlights the company’s growth and commercial momentum for its portfolio—including Dayspring®